Prostate cancer is one of the most common malignancies in the male genitourinary system, and it is also the cancer with the fastest-growing incidence and mortality rates among men in China. Although prostate cancer screening can significantly reduce mortality, China has not yet established a well-developed screening system, which is one of the reasons why its mortality rate remains notably higher than that of Western countries. The primary objective of this project is to establish an efficient screening-diagnosis-treatment pathway, beginning with screening in community hospitals, followed by definitive diagnosis in secondary hospitals, and finally treatment in tertiary hospitals. Additionally, the project aims to achieve multi-institutional and multi-terminal sharing of disease information as well as dynamic monitoring and follow-up. The feasibility and effectiveness of this model will be validated through statistical analysis of the data.
Study Type
OBSERVATIONAL
Enrollment
3,000
No intervention
Department of Urology, Peking University First Hospital, Beijing, 100034
Beijing, China
RECRUITINGSerum PSA level
Time frame: from 2025 to 2027
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.